ERBB2 and breast neoplasm: Quantitation of miR-183 by RQ-PCR in primary breast tumors revealed that miR-183 expression is significantly lower in ER and PR positive compared to ER and PR negative breast tumors, while miR-183 expression was significantly higher in HER2/neu positive compared to HER2/neu negative tumors.